Tue, January 8, 2019
Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018

Matt Miksic Initiated (BSX) at Buy and Held Target at $42 on, Dec 18th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-42-on-dec-18th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt Miksic of Credit Suisse, Initiated "Boston Scientific Corporation" (BSX) at Buy and Held Target at $42 on, Dec 18th, 2018.

Matt has made no other calls on BSX in the last 4 months.



There are 6 other peers that have a rating on BSX. Out of the 6 peers that are also analyzing BSX, 0 agree with Matt's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matt


  • John Eade of "Argus Research" Maintained at Strong Buy with Increased Target to $43 on, Friday, October 26th, 2018
  • Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $42 on, Thursday, October 25th, 2018
  • Travis Steed of "Barclays" Initiated at Buy and Held Target at $43 on, Tuesday, October 16th, 2018
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $48 on, Tuesday, October 2nd, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $42 on, Monday, September 17th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $41 on, Tuesday, September 4th, 2018